{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:24:11Z","timestamp":1790648651006,"version":"4.1.0"},"reference-count":250,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described as highly selective for helper T type 2 (Th2) cells. Later, its expression was extended to other T cell subsets such as regulatory T (Treg) cells and Th17 cells. CCR4 has long been regarded as a potential therapeutic target for allergic diseases such as atopic dermatitis and bronchial asthma. Furthermore, the findings showing that CCR4 is strongly expressed by T cell malignancies such as adult T cell leukemia\/lymphoma (ATLL) and cutaneous T cell lymphomas (CTCLs) have led to the development and clinical application of the fully humanized and glyco-engineered monoclonal anti-CCR4 Mogamulizumab in refractory\/relapsed ATLL and CTCLs with remarkable successes. However, Mogamulizumab often induces severe adverse events in the skin possibly because of its efficient depletion of Treg cells. In particular, treatment with Mogamulizumab prior to allogenic hematopoietic stem cell transplantation (allo-HSCT), the only curative option of these T cell malignancies, often leads to severe glucocorticoid-refractory graft-versus-host diseases. The efficient depletion of Treg cells by Mogamulizumab has also led to its clinical trials in advanced solid tumors singly or in combination with immune checkpoint inhibitors. The main focus of this review is CCR4; its expression on normal and malignant T cells and its significance as a therapeutic target in cancer immunotherapy.<\/jats:p>","DOI":"10.3390\/cancers13215542","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T22:25:54Z","timestamp":1636064754000},"page":"5542","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["CCR4 as a Therapeutic Target for Cancer Immunotherapy"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4353-5809","authenticated-orcid":false,"given":"Osamu","family":"Yoshie","sequence":"first","affiliation":[{"name":"Health and Kampo Institute, Sendai 981-3205, Japan"},{"name":"Kindai University, Osaka 577-8502, Japan"},{"name":"Aoinosono-Sendai Izumi Long-Term Health Care Facility, Sendai 981-3126, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: From bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy","volume":"10","author":"Massara","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0065-2776(01)78002-9","article-title":"Chemokines in immunity","volume":"78","author":"Yoshie","year":"2001","journal-title":"Adv. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: Redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1189\/jlb.2MR0815-380R","article-title":"Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes","volume":"99","author":"Hauser","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"19495","DOI":"10.1074\/jbc.270.33.19495","article-title":"Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line","volume":"270","author":"Power","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"Imai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","article-title":"Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4","volume":"273","author":"Imai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"21514","DOI":"10.1074\/jbc.271.35.21514","article-title":"Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector","volume":"271","author":"Imai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","article-title":"Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells","volume":"185","author":"Godiska","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25229","DOI":"10.1074\/jbc.272.40.25229","article-title":"Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes","volume":"272","author":"Chang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/geno.1996.4552","article-title":"Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13","volume":"40","author":"Nomiyama","year":"1997","journal-title":"Genomics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000015000","article-title":"Human chemokines fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13","volume":"81","author":"Nomiyama","year":"1998","journal-title":"Cytogenet. Cell Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1182\/blood.V89.12.4448","article-title":"Molecular cloning and characterization of a cDNA, CHEMR1, encoding a chemokine receptor with a homology to the human C-C chemokine receptor, CCR-4","volume":"89","author":"Youn","year":"1997","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1084\/jem.188.3.451","article-title":"Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells","volume":"188","author":"Schaniel","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.0.CO;2-Y","article-title":"The murine beta-chemokine TARC is expressed by subsets of dendritic cells and attracts primed CD4+ T cells","volume":"29","author":"Lieberam","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<2934::AID-IMMU2934>3.0.CO;2-Q","article-title":"Three chemokines with potential functions in T lymphocyte-independent and -dependent B lymphocyte stimulation","volume":"29","author":"Schaniel","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/gb-2006-7-12-243","article-title":"The chemokine and chemokine receptor superfamilies and their molecular evolution","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Genome Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.4049\/jimmunol.1300232","article-title":"Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy","volume":"192","author":"Viney","year":"2014","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/eji.200324429","article-title":"Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells","volume":"34","author":"Mariani","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/23495","article-title":"The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells","volume":"400","author":"Campbell","year":"1999","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1074\/jbc.274.7.3988","article-title":"Truncation of macrophage-derived chemokine by CD26\/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction","volume":"274","author":"Proost","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-065X.2003.00067.x","article-title":"Chemokines in the systemic organization of immunity","volume":"195","author":"Campbell","year":"2003","journal-title":"Immunol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.molimm.2004.06.040","article-title":"Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues","volume":"42","author":"Ebert","year":"2005","journal-title":"Mol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri.2016.116","article-title":"Dendritic cell migration in health and disease","volume":"17","author":"Worbs","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smim.2003.08.007","article-title":"Chemokine regulation of naive T cell traffic in health and disease","volume":"15","author":"Weninger","year":"2003","journal-title":"Semin. Immunol."},{"key":"ref_30","first-page":"11","article-title":"Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus","volume":"3","author":"Chiba","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.immuni.2018.02.010","article-title":"Understanding Subset Diversity in T Cell Memory","volume":"48","author":"Jameson","year":"2018","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00062752-200101000-00009","article-title":"Th1 and Th2 cells","volume":"8","author":"Dong","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","article-title":"Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine","volume":"11","author":"Imai","year":"1999","journal-title":"Int. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1189\/jlb.68.4.568","article-title":"Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells","volume":"68","author":"Yamamoto","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/intimm\/dxf044","article-title":"IFN-gamma-inducible expression of thymus and activation-regulated chemokine\/CCL17 and macrophage-derived chemokine\/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis","volume":"14","author":"Horikawa","year":"2002","journal-title":"Int. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1067\/mai.2002.126079","article-title":"Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis","volume":"110","author":"Fujisawa","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1346-8138.12440","article-title":"Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis","volume":"41","author":"Kataoka","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ijlh.13141","article-title":"Expression of Th1\/Th2 cell-related chemokine receptors on CD4(+) lymphocytes under physiological conditions","volume":"42","author":"Watanabe","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"986789","DOI":"10.1155\/2013\/986789","article-title":"Th17 cells in immunity and autoimmunity","volume":"2013","author":"Bedoya","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Rivino","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat. Immunol."},{"key":"ref_49","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ultras.2008.05.002","article-title":"The use of acoustic radiation forces to position particles within fluid droplets","volume":"49","author":"Oberti","year":"2009","journal-title":"Ultrasonics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nm.2760","article-title":"T cell homing to epithelial barriers in allergic disease","volume":"18","author":"Islam","year":"2012","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E","article-title":"Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin","volume":"32","author":"Stagg","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.20031244","article-title":"Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): Requirement for GALT dendritic cells and adjuvant","volume":"198","author":"Svensson","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature01726","article-title":"Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells","volume":"424","author":"Mora","year":"2003","journal-title":"Nature"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20011502","article-title":"Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues","volume":"195","author":"Campbell","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4049\/jimmunol.172.2.857","article-title":"Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: Role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets","volume":"172","author":"Dudda","year":"2004","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ni1433","article-title":"DCs metabolize sunlight-induced vitamin D3 to \u2019program\u2019 T cell attraction to the epidermal chemokine CCL27","volume":"8","author":"Sigmundsdottir","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.4049\/jimmunol.180.5.2786","article-title":"1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells","volume":"180","author":"Shirakawa","year":"2008","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaci.2014.03.010","article-title":"CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin","volume":"134","author":"Xia","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.4049\/jimmunol.1701377","article-title":"CCR8 Expression Defines Tissue-Resident Memory T Cells in Human Skin","volume":"200","author":"McCully","year":"2018","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4049\/jimmunol.1402961","article-title":"Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells","volume":"195","author":"McCully","year":"2015","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/intimm\/dxu098","article-title":"CCR8 regulates contact hypersensitivity by restricting cutaneous dendritic cell migration to the draining lymph nodes","volume":"27","author":"Yabe","year":"2015","journal-title":"Int. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1084\/jem.20130091","article-title":"Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4","volume":"210","author":"Mikhak","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12977-019-0504-z","article-title":"Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes","volume":"16","author":"Afonso","year":"2019","journal-title":"Retrovirology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fmicb.2020.01124","article-title":"Epidemiology of HTLV-1 Infection and ATL in Japan: An Update","volume":"11","author":"Iwanaga","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1182\/blood-2008-03-136770","article-title":"HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse","volume":"114","author":"Nejmeddine","year":"2009","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gross, C., and Thoma-Kress, A.K. (2016). Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission. Viruses, 8.","DOI":"10.3390\/v8030074"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/v2071427","article-title":"The HTLV-1 Virological Synapse","volume":"2","author":"Nejmeddine","year":"2010","journal-title":"Viruses"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Furuta, R., Yasunaga, J.I., Miura, M., Sugata, K., Saito, A., Akari, H., Ueno, T., Takenouchi, N., Fujisawa, J.I., and Koh, K.R. (2017). Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006722"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1745","article-title":"Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells","volume":"14","author":"Jones","year":"2008","journal-title":"Nat. Med."},{"key":"ref_79","first-page":"210","article-title":"Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: An update","volume":"7","author":"Thomson","year":"2005","journal-title":"AIDS Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmv.23181","article-title":"Current prevalence of HTLV-1 in Japan as determined by screening of blood donors","volume":"84","author":"Satake","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11899-018-0458-6","article-title":"Adult T Cell Leukemia-Lymphoma (ATL): State of the Art","volume":"13","author":"Phillips","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fmicb.2012.00406","article-title":"HTLV tax: A fascinating multifunctional co-regulator of viral and cellular pathways","volume":"3","author":"Currer","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mohanty, S., and Harhaj, E.W. (2020). Mechanisms of Oncogenesis by HTLV-1 Tax. Pathogens, 9.","DOI":"10.3390\/pathogens9070543"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/jvi.66.5.2928-2933.1992","article-title":"Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells","volume":"66","author":"Kannagi","year":"1992","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12977-016-0249-x","article-title":"Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis","volume":"13","author":"Ma","year":"2016","journal-title":"Retrovirology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Giam, C.Z., and Semmes, O.J. (2016). HTLV-1 Infection and Adult T-Cell Leukemia\/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Viruses, 8.","DOI":"10.3390\/v8060161"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JOP.2017.021907","article-title":"Adult T-Cell Leukemia\/Lymphoma","volume":"13","author":"Ratner","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.seminhematol.2021.02.005","article-title":"Diagnosis and management of adult T-cell leukemia\/lymphoma","volume":"58","author":"Ishitsuka","year":"2021","journal-title":"Semin. Hematol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cas.12617","article-title":"Recent advances in the treatment of adult T-cell leukemia-lymphomas","volume":"106","author":"Utsunomiya","year":"2015","journal-title":"Cancer Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3389\/fmicb.2019.02235","article-title":"Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma","volume":"10","author":"Utsunomiya","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: A retrospective cohort study","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107669","DOI":"10.1016\/j.pharmthera.2020.107669","article-title":"An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers","volume":"218","author":"Yamauchi","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1128\/jvi.70.12.8508-8517.1996","article-title":"Differential transactivation of the intercellular adhesion molecule 1 gene promoter by Tax1 and Tax2 of human T-cell leukemia viruses","volume":"70","author":"Tanaka","year":"1996","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/aid.1997.13.1429","article-title":"Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element","volume":"13","author":"Owen","year":"1997","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","article-title":"Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells","volume":"180","author":"Hieshima","year":"2008","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","article-title":"Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells","volume":"185","author":"Toulza","year":"2010","journal-title":"J. Immunol."},{"key":"ref_100","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: Its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1349-7006.2005.00080.x","article-title":"Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells","volume":"96","author":"Kohno","year":"2005","journal-title":"Cancer Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1346-8138.12328","article-title":"Skin manifestations of adult T-cell leukemia\/lymphoma: Clinical, cytological and immunological features","volume":"41","author":"Tokura","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/10428190600775599","article-title":"Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia\/lymphoma","volume":"47","author":"Harasawa","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V95.1.30","article-title":"Increased chemokine receptor CCR7\/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells","volume":"95","author":"Hasegawa","year":"2000","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.22483","article-title":"Expression of CCR9 in HTLV-1+ T cells and ATL cells expressing Tax","volume":"120","author":"Nagakubo","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/sj.onc.1210984","article-title":"Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia","volume":"27","author":"Nakayama","year":"2008","journal-title":"Oncogene"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0950-3552(88)80044-0","article-title":"Anti-oestrogens in the treatment of breast and gynaecological cancers","volume":"2","author":"Furr","year":"1988","journal-title":"Baillieres Clin. Obstet. Gynaecol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3389\/fmicb.2017.02686","article-title":"Hijacking of the AP-1 Signaling Pathway during Development of ATL","volume":"8","author":"Gazon","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Garces de Los Fayos Alonso, I., Liang, H.C., Turner, S.D., Lagger, S., Merkel, O., and Kenner, L. (2018). The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. Cancers, 10.","DOI":"10.3390\/cancers10040093"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2012-07-441022","article-title":"SOX4 is a direct target gene of FRA-2 and induces expression of HDAC8 in adult T-cell leukemia\/lymphoma","volume":"121","author":"Higuchi","year":"2013","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Nasu, A., Gion, Y., Nishimura, Y., Nishikori, A., Sakamoto, M., Egusa, Y., Fujita, A., Yoshino, T., and Sato, Y. (2021). Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia\/Lymphoma. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050766"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3324\/haematol.2017.177279","article-title":"Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas","volume":"103","author":"Kitadate","year":"2018","journal-title":"Haematologica"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1015320321511","article-title":"Role of the CC chemokine receptor 9\/TECK interaction in apoptosis","volume":"7","author":"Youn","year":"2002","journal-title":"Apoptosis"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/immu.200310025","article-title":"CCR8-dependent activation of the RAS\/MAPK pathway mediates anti-apoptotic activity of I-309\/CCL1 and vMIP-I","volume":"33","author":"Louahed","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cvr\/cvp341","article-title":"Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling","volume":"85","author":"White","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1222","article-title":"Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia","volume":"105","author":"Sasaki","year":"2005","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3960\/jslrt.52.17","article-title":"CADM1\/TSLC1 is a novel cell surface marker for adult T-cell leukemia\/lymphoma","volume":"52","author":"Nakahata","year":"2012","journal-title":"J. Clin. Exp. Hematopathol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Manivannan, K., Rowan, A.G., Tanaka, Y., Taylor, G.P., and Bangham, C.R. (2016). CADM1\/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005560"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s13365-020-00838-z","article-title":"Expression of TSLC1 in patients with HAM\/TSP","volume":"26","author":"Takenouchi","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1111\/cas.14219","article-title":"CD4(+) CADM1(+) cell percentage predicts disease progression in HTLV-1 carriers and indolent adult T-cell leukemia\/lymphoma","volume":"110","author":"Makiyama","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1074\/jbc.M109.076653","article-title":"CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells","volume":"285","author":"Masuda","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12788\/j.sder.2018.002","article-title":"Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Cerroni","year":"2018","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/jid.2014.356","article-title":"CD158k is a reliable marker for diagnosis of Sezary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells","volume":"135","author":"Daubord","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J. Investig. Dermatol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J. Investig. Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: Malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/leu.2011.237","article-title":"Regulatory T cells and immunodeficiency in mycosis fungoides and Sezary syndrome","volume":"26","author":"Krejsgaard","year":"2012","journal-title":"Leukemia"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3892\/ijo.2014.2524","article-title":"Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia\/lymphoma","volume":"45","author":"Hashikawa","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides","volume":"115","author":"Lu","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.13054","article-title":"Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides","volume":"171","author":"Daggett","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12253-012-9529-5","article-title":"Tissue-specific homing of immune cells in malignant skin tumors","volume":"18","author":"Jokai","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1158\/0008-5472.CAN-08-0602","article-title":"CXCL13 is highly produced by Sezary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines","volume":"68","author":"Picchio","year":"2008","journal-title":"Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"ref_141","first-page":"1367","article-title":"Expression and function of FRA2\/JUND in cutaneous T-cell lymphomas","volume":"32","author":"Nakayama","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ajh.20952","article-title":"Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: Reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine","volume":"82","author":"Richardson","year":"2007","journal-title":"Am. J. Hematol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","article-title":"Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12185-017-2270-9","article-title":"Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: Interim results of postmarketing all-case surveillance","volume":"106","author":"Ishitsuka","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/ejh.13474","article-title":"Clinical efficacy of mogamulizumab for relapsed\/refractory aggressive adult T-cell leukemia\/lymphoma: A retrospective analysis","volume":"105","author":"Satake","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cjp2.180","article-title":"Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia\/lymphoma","volume":"7","author":"Fujii","year":"2021","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/1078-0432.CCR-14-0830","article-title":"Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive\/refractory mycosis fungoides and Sezary syndrome","volume":"21","author":"Ni","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1158\/1078-0432.CCR-19-2030","article-title":"FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sezary Syndrome","volume":"25","author":"Kasamon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.2147\/DDDT.S185896","article-title":"Spotlight on Mogamulizumab-Kpkc for Use in Adults with Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome: Efficacy, Safety, and Patient Selection","volume":"14","author":"Blackmon","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1172\/JCI75250","article-title":"HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells","volume":"124","author":"Araya","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.08.012","article-title":"HTLV-1 induces a Th1-like state in CD4(+)CCR4(+) T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP","volume":"304","author":"Yamano","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","article-title":"Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy","volume":"378","author":"Sato","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Zhang, T., Sun, J., Li, J., Zhao, Y., Zhang, T., Yang, R., and Ma, X. (2021). Safety and efficacy profile of mogamulizumab (Poteligeo) in the treatment of cancers: An update evidence from 14 studies. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08363-w"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/1346-8138.12419","article-title":"Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: Cutaneous adverse reactions may predict the prognosis","volume":"41","author":"Yonekura","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/cas.12116","article-title":"Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma","volume":"104","author":"Ishida","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2340\/00015555-2027","article-title":"Stevens-Johnson Syndrome Associated with Mogamulizumab-induced Deficiency of Regulatory T cells in an Adult T-cell Leukaemia Patient","volume":"95","author":"Honda","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Issa, F., Hester, J., Milward, K., and Wood, K.J. (2012). Homing of regulatory T cells to human skin is important for the prevention of alloimmune-mediated pathology in an in vivo cellular therapy model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0053331"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/1078-0432.CCR-18-2575","article-title":"Mogamulizumab Treatment Elicits Autoantibodies Attacking the Skin in Patients with Adult T-Cell Leukemia-Lymphoma","volume":"25","author":"Suzuki","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1182\/bloodadvances.2020001641","article-title":"Robust CD8+ T-cell proliferation and diversification after mogamulizumab in patients with adult T-cell leukemia-lymphoma","volume":"4","author":"Saito","year":"2020","journal-title":"Blood Adv."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamadermatol.2021.0877","article-title":"Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sezary Syndrome","volume":"157","author":"Hirotsu","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1684\/ejd.2021.4002","article-title":"Mogamulizumab-induced vitiligo in patients with Sezary syndrome: Three cases","volume":"31","author":"Algarni","year":"2021","journal-title":"Eur. J. Dermatol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/imm.12791","article-title":"Regulatory T cells in skin","volume":"152","author":"Ali","year":"2017","journal-title":"Immunology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/hepr.12117","article-title":"Reactivation of hepatitis B virus in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab","volume":"44","author":"Nakano","year":"2014","journal-title":"Hepatol. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/hepr.12513","article-title":"Fatal reactivation of hepatitis B virus infection in a patient with adult T-cell leukemia-lymphoma receiving the anti-CC chemokine receptor 4 antibody mogamulizumab","volume":"45","author":"Ifuku","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"100601","DOI":"10.1016\/j.eclinm.2020.100601","article-title":"Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database","volume":"28","author":"Wang","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2169\/internalmedicine.8781-16","article-title":"Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment","volume":"56","author":"Tanaka","year":"2017","journal-title":"Intern. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12185-018-2552-x","article-title":"Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution","volume":"109","author":"Kamachi","year":"2019","journal-title":"Int. J. Hematol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2169\/internalmedicine.55.5644","article-title":"Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient","volume":"55","author":"Ishii","year":"2016","journal-title":"Intern. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00277-014-2239-1","article-title":"Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia\/lymphoma patient","volume":"94","author":"Taguchi","year":"2015","journal-title":"Ann. Hematol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bjh.12555","article-title":"Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma","volume":"163","author":"Ohno","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1200\/JCO.2005.02.774","article-title":"Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides","volume":"23","author":"Molina","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1158\/0008-5472.CAN-16-1311","article-title":"Allogeneic Stem Cell Transplantation: A Historical and Scientific Overview","volume":"76","author":"Singh","year":"2016","journal-title":"Cancer Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41571-020-0356-4","article-title":"Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD","volume":"17","author":"Blazar","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of graft-versus-host disease","volume":"43","author":"Ferrara","year":"2006","journal-title":"Semin. Hematol."},{"key":"ref_184","first-page":"97","article-title":"The chemokine system: A possible therapeutic target in acute graft versus host disease","volume":"341","author":"Kittan","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia\/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/sci.2016.09.13","article-title":"Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"3","author":"Fuji","year":"2016","journal-title":"Stem Cell Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1060028019884863","article-title":"Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas","volume":"54","author":"Moore","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/14737140.2020.1760096","article-title":"Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: Safety and efficacy","volume":"20","author":"Lewis","year":"2020","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12185-016-2087-y","article-title":"Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia\/lymphoma: A report of two cases","volume":"104","author":"Tsubokura","year":"2016","journal-title":"Int. J. Hematol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-immunol-042617-053402","article-title":"Cancer Neoantigens","volume":"37","author":"Schumacher","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Ma, W., Pham, B., and Li, T. (2021). Cancer neoantigens as potential targets for immunotherapy. Clin. Exp. Metastasis.","DOI":"10.1007\/s10585-021-10091-1"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: Integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"Teng","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: A common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Perrier, A., Didelot, A., Laurent-Puig, P., Blons, H., and Garinet, S. (2020). Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors. Biomolecules, 10.","DOI":"10.3390\/biom10071061"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3389\/fimmu.2019.02254","article-title":"Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells","volume":"10","author":"Anderson","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired Resistance to Immune Checkpoint Inhibitors","volume":"37","author":"Schoenfeld","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-018-0479-7","article-title":"High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors","volume":"6","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"e126908","DOI":"10.1172\/jci.insight.126908","article-title":"PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers","volume":"4","author":"Yarchoan","year":"2019","journal-title":"JCI Insight"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-67577-0_2","article-title":"Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment","volume":"1036","author":"Gajewski","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/978-1-4939-3387-7_43","article-title":"Cancer Vaccines: A Brief Overview","volume":"1403","author":"Thomas","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/14760584.2018.1434000","article-title":"Current challenges for cancer vaccine adjuvant development","volume":"17","author":"Bowen","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.3389\/fimmu.2018.02775","article-title":"A Highly Active Form of XCL1\/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8(+) T Cells","volume":"9","author":"Matsuo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tripleo.2009.12.015","article-title":"Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma","volume":"109","author":"Watanabe","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion","volume":"21","author":"Hatzioannou","year":"2020","journal-title":"Nat. Immunol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"716342","DOI":"10.3389\/fimmu.2021.716342","article-title":"Systemic Inflammation Associates With a Myeloid Inflamed Tumor Microenvironment in Primary Resected Colon Cancer-May Cold Tumors Simply Be Too Hot?","volume":"12","author":"Kostner","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/ijc.23042","article-title":"Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia\/lymphoma","volume":"121","author":"Shimauchi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prp.2018.10.001","article-title":"Clinical and histopathological significance of PD-1 expression in cutaneous lesions of adult T-cell leukemia-lymphoma","volume":"215","author":"Higuchi","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","article-title":"PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia\/lymphoma","volume":"128","author":"Miyoshi","year":"2016","journal-title":"Blood"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00277-020-03967-x","article-title":"Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma","volume":"99","author":"Takeuchi","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2019-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1056\/NEJMc1803181","article-title":"Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy","volume":"378","author":"Ratner","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.2019002038","article-title":"Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating Tregs after PD-1 blockade","volume":"134","author":"Rauch","year":"2019","journal-title":"Blood"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2020.00492","article-title":"How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?","volume":"11","author":"Denis","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMc1807852","article-title":"PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma","volume":"379","author":"Ishitsuka","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"733770","DOI":"10.3389\/fonc.2021.733770","article-title":"Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives","volume":"11","author":"Roccuzzo","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.19.01056","article-title":"Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sezary Syndrome: A Multicenter Phase II Study","volume":"38","author":"Khodadoust","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12307-012-0122-y","article-title":"Tumor-infiltrating regulatory T cells: Phenotype, role, mechanism of expansion in situ and clinical significance","volume":"6","author":"Tanchot","year":"2013","journal-title":"Cancer Microenviron."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","article-title":"Regulatory T-cell compartmentalization and trafficking","volume":"108","author":"Wei","year":"2006","journal-title":"Blood"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1158\/0008-5472.CAN-09-1642","article-title":"Differences in tumor regulatory T-cell localization and activation status impact patient outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jop.12885","article-title":"Macrophage CCL22 expression in the tumor microenvironment and implications for survival in patients with squamous cell carcinoma of the tongue","volume":"48","author":"Kimura","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1182\/blood-2011-01-329656","article-title":"A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens","volume":"118","author":"Pere","year":"2011","journal-title":"Blood"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000431059","article-title":"Clinical Application of Anti-CCR4 Monoclonal Antibody","volume":"89","author":"Ueda","year":"2015","journal-title":"Oncology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"e1090075","DOI":"10.1080\/2162402X.2015.1090075","article-title":"Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model","volume":"5","author":"Chang","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jphs.2018.02.001","article-title":"A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment","volume":"136","author":"Yamamoto","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/2326-6066.CIR-18-0751","article-title":"CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer","volume":"7","author":"Maeda","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1021\/acs.jmedchem.0c00988","article-title":"Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors","volume":"63","author":"Robles","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1349-7006.2006.00307.x","article-title":"CCR4 as a novel molecular target for immunotherapy of cancer","volume":"97","author":"Ishida","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1158\/1078-0432.CCR-19-1090","article-title":"A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors","volume":"25","author":"Doi","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1158\/1078-0432.CCR-20-0328","article-title":"Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study","volume":"26","author":"Zamarin","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1182\/bloodadvances.2020003053","article-title":"Mogamulizumab for adult T-cell leukemia-lymphoma: A multicenter prospective observational study","volume":"4","author":"Yonekura","year":"2020","journal-title":"Blood Adv."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12185-019-02728-5","article-title":"CCR4 is rarely expressed in CCR4-mutated T\/NK-cell lymphomas other than adult T-cell leukemia\/lymphoma","volume":"110","author":"Sakamoto","year":"2019","journal-title":"Int. J. Hematol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2018-02-835991","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22536","article-title":"Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells","volume":"120","author":"Yano","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"e002193","DOI":"10.1136\/jitc-2020-002193","article-title":"Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: Implications for combination therapy with antitumor antibodies","volume":"9","author":"Dubois","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cellimm.2017.10.015","article-title":"The paradox of Th17 cell functions in tumor immunity","volume":"322","author":"Asadzadeh","year":"2017","journal-title":"Cell. Immunol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2016.04.039","article-title":"CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma","volume":"378","author":"Matsuo","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.166.1.103","article-title":"C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential","volume":"166","author":"Andrew","year":"2001","journal-title":"J. Immunol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/intimm\/dxp019","article-title":"Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines","volume":"21","author":"Kondo","year":"2009","journal-title":"Int. Immunol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5542\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:26:00Z","timestamp":1760167560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/21\/5542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":250,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cancers13215542"],"URL":"https:\/\/doi.org\/10.3390\/cancers13215542","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}